| 000 | 01561 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250515175132.0 | ||
| 264 | 0 | _c20091104 | |
| 008 | 200911s 0 0 eng d | ||
| 022 | _a1473-4877 | ||
| 024 | 7 |
_a10.1185/03007990903094361 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGraefe-Mody, E U | |
| 245 | 0 | 0 |
_aEvaluation of the potential for steady-state pharmacokinetic and pharmacodynamic interactions between the DPP-4 inhibitor linagliptin and metformin in healthy subjects. _h[electronic resource] |
| 260 |
_bCurrent medical research and opinion _cAug 2009 |
||
| 300 |
_a1963-72 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aCross-Over Studies |
| 650 | 0 | 4 |
_aDipeptidyl-Peptidase IV Inhibitors _xadministration & dosage |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aDrug Interactions |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypoglycemic Agents _xadministration & dosage |
| 650 | 0 | 4 | _aLinagliptin |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMetformin _xadministration & dosage |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPurines _xadministration & dosage |
| 650 | 0 | 4 |
_aQuinazolines _xadministration & dosage |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aPadula, S | |
| 700 | 1 | _aRing, A | |
| 700 | 1 | _aWithopf, B | |
| 700 | 1 | _aDugi, K A | |
| 773 | 0 |
_tCurrent medical research and opinion _gvol. 25 _gno. 8 _gp. 1963-72 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1185/03007990903094361 _zAvailable from publisher's website |
| 999 |
_c18970184 _d18970184 |
||